zimberelimab,domvanalimab,etrumadenant
Arcus Biosciences,Gilead,Otsuka
['nsclc', 'sclc']
will there be a role for anti-tigit in advanced nsclc? with an update on phase 2 study of dom (anti-tigit) + zim (anti-pd1) vs zim alone in high pd-l1 population. multiple anti-tigit p3 trials ongoing. #asco23 
Medical oncology fellow @MSKcancercenter, prior @oslerresidency @harvardmed @yale. Precision medicine, thoracic cancers, Miami sports.